Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
Authors
Keywords
Bladder cancer, Diabetes, Epidemiology, Metformin, Taiwan
Journal
ACTA DIABETOLOGICA
Volume 51, Issue 2, Pages 295-303
Publisher
Springer Nature
Online
2014-02-08
DOI
10.1007/s00592-014-0562-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
- (2013) Matteo Monami et al. ACTA DIABETOLOGICA
- Diabetes mellitus and cancer in Werner syndrome
- (2013) Julia M. Lauper et al. ACTA DIABETOLOGICA
- Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan
- (2013) Chin-Hsiao Tseng ACTA DIABETOLOGICA
- Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan
- (2013) Chin-Hsiao Tseng BMC CANCER
- Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
- (2013) Zhaowei Zhu et al. BMC CANCER
- Rosiglitazone is not associated with an increased risk of bladder cancer
- (2013) Chin-Hsiao Tseng Cancer Epidemiology
- Insulin Use and Smoking Jointly Increase the Risk of Bladder Cancer Mortality in Patients With Type 2 Diabetes
- (2013) Chin-Hsiao Tseng Clinical Genitourinary Cancer
- Peroxisome Proliferator-Activated Receptor Agonists and Bladder Cancer: Lessons from Animal Studies
- (2013) CHIN-HSIAO TSENG et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS
- Effects of Metformin Dose on Cancer Risk Reduction in Patients with Type 2 Diabetes Mellitus: A 6-Year Follow-up Study
- (2013) Hsiu-Chen Lin et al. PHARMACOTHERAPY
- Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
- (2013) Zhaowei Zhu et al. PLoS One
- Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry
- (2012) Xilin Yang et al. ACTA DIABETOLOGICA
- Japanese diabetic patients with Werner syndrome exhibit high incidence of cancer
- (2012) Shunichiro Onishi et al. ACTA DIABETOLOGICA
- Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies
- (2012) Fan Zhang et al. ACTA DIABETOLOGICA
- Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up
- (2012) Gianluca Perseghin et al. ACTA DIABETOLOGICA
- Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells
- (2012) Qing-you Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer
- (2012) Tibor Szarvas et al. BJU INTERNATIONAL
- Metformin and breast cancer risk: a meta-analysis and critical literature review
- (2012) Nananda F. Col et al. BREAST CANCER RESEARCH AND TREATMENT
- The influence of antidiabetic medications on the development and progression of prostate cancer
- (2012) Anna Hitron et al. Cancer Epidemiology
- Statin Use as a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients
- (2012) D. M. Lehman et al. DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
- (2012) J. A. Johnson et al. DIABETOLOGIA
- Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
- (2012) Chin-Hsiao Tseng EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
- (2012) Ming-Chia Hsieh et al. Experimental Diabetes Research
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
- (2012) Rowan T. Chlebowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Pioglitazone and bladder cancer in human studies: Is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
- (2012) Chin-Hsiao Tseng JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Proline-Rich Tyrosine Kinase 2 (Pyk2) Regulates IGF-I-Induced Cell Motility and Invasion of Urothelial Carcinoma Cells
- (2012) Marco Genua et al. PLoS One
- Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
- (2011) Emily Jane Gallagher et al. Annals of the New York Academy of Sciences
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antidiabetes Drugs Correlate With Decreased Risk of Lung Cancer: A Population-Based Observation in Taiwan
- (2011) Shih-Wei Lai et al. Clinical Lung Cancer
- Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
- (2011) C.-H. Tseng DIABETES CARE
- Diabetes and Risk of Prostate Cancer: A study using the National Health Insurance
- (2011) C.-H. Tseng DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
- (2011) Z.-J. Zhang et al. DIABETES CARE
- Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings-what, why and how?
- (2011) X. L. Yang et al. DIABETES OBESITY & METABOLISM
- Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
- (2011) C.-H. Tseng DIABETOLOGIA
- Significantly Increased Risk of Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2011) Hiroshi Noto et al. Endocrine Practice
- Metformin and cancer: new applications for an old drug
- (2011) Taxiarchis V. Kourelis et al. MEDICAL ONCOLOGY
- Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy
- (2011) Zhongbo Liu et al. MOLECULAR CARCINOGENESIS
- Metformin and neoplasia: Implications and indications
- (2011) Ahmad Aljada et al. PHARMACOLOGY & THERAPEUTICS
- Effects of potassium channel modulators on myogenic spontaneous phasic contractile activity in human detrusor from neurogenic patients
- (2010) Stephanie Oger et al. BJU INTERNATIONAL
- Bladder Cancer in 2010: How Far have We Come?
- (2010) B. L. Jacobs et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
- (2010) Xilin Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
- (2010) P. D. Home et al. DIABETOLOGIA
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Urothelial overexpression of insulin-like growth factor-1 increases susceptibility top-cresidine-induced bladder carcinogenesis in transgenic mice
- (2009) Stephen D. Hursting et al. MOLECULAR CARCINOGENESIS
- Bias: Considerations for research practice
- (2008) T. Gerhard AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now